Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07693205 · ClinicalTrials.gov registry record · Phase 4

A Prospective, Randomized, Subject- and Examiner-Masked, Multicenter Study Comparing Bilateral Clareon TruPlus and Bilateral Clareon Monofocal Intraocular Lens Implantation (Spherical and Toric) in Cataract Subjects

A Phase 4 study, sponsored by Berkeley Eye Center.

Recruiting
Registry status
Phase 4
Development phase
180
Enrollment target

NCT07693205 is a Phase 4 study that is actively recruiting participants, run by Berkeley Eye Center. The registered enrollment target is 180 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07693205, a Phase 4 study, is actively recruiting participants, sponsored by Berkeley Eye Center.

RECRUITING
Registry status
Phase 4
Development phase
180 participants
Enrollment target

Study Summary

This investigator-initiated trial is a prospective, randomized, parallel-group, bilateral implantation study comparing Clareon TruPlus versus Clareon monofocal intraocular lenses (IOLs). Spherical and toric models are permitted in both arms based on standardized preoperative planning and clinical indication. Subjects and postoperative examiners/technicians will be masked to IOL assignment; surgeons will not be masked. The overall structure is modeled after randomized bilateral implantation cataract study designs with a Month 3 primary endpoint visit.

Interventions

  • DEVICE Clareon TruPlus
  • DEVICE Clareon monofocal

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2026-07
Est. Completion 2027-07
Phase Phase 4

Sponsor

Berkeley Eye Center

8 total trials

What the Registry Record Tells You About NCT07693205

The ClinicalTrials.gov registry entry for NCT07693205 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Berkeley Eye Center, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Clareon TruPlus is the first listed.

NCT07693205 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07693205 about?

NCT07693205 is a clinical study titled "A Prospective, Randomized, Subject- and Examiner-Masked, Multicenter Study Comparing Bilateral Clareon TruPlus and Bilateral Clareon Monofocal Intraocular Lens Implantation (Spherical and Toric) in Cataract Subjects". This investigator-initiated trial is a prospective, randomized, parallel-group, bilateral implantation study comparing Clareon TruPlus versus Clareon monofocal intraocular lenses (IOLs). Spherical and toric models are permitted in both arms based on standardized preoperative planning and clinical in...

What is the current status of trial NCT07693205?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 180 participants. The study started on 2026-07. Estimated completion is 2027-07.

What interventions are being tested in trial NCT07693205?

The interventions under investigation include: Clareon TruPlus (DEVICE), Clareon monofocal (DEVICE).

Who is sponsoring clinical trial NCT07693205?

This trial is sponsored by Berkeley Eye Center, which has 8 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.